logo
Why childhood vaccines matter: Paediatrician raises concern on the alarming decline in global vaccine coverage

Why childhood vaccines matter: Paediatrician raises concern on the alarming decline in global vaccine coverage

Hindustan Times3 days ago
Most parents in India follow the vaccination schedule because it's part of growing up. But beyond that routine lies a worrying trend. Global childhood immunisation, which once saw steady progress, is now slowing, and millions of children remain vulnerable to diseases we thought were under control. According to a 2025 update by the WHO and Unicef, 14.3 million infants worldwide received no vaccines at all last year, while another 20 million missed at least one critical dose of the DTP vaccine, which protects against diphtheria, tetanus, and pertussis. Childhood should be protected, not paused. Vaccines help make that possible.(Adobe Stock)
In clinical practice, this is more than data—it's visible in children who arrive with infections that could have been avoided, and in communities dealing with outbreaks that spread simply because protection levels dropped.
Dr Vignatha Sajja, Consultant Paediatrician, Arete Hospitals, shares with Health Shots, five essential reasons why timely childhood vaccination matter more than ever:
1. Protection when the body is still learning
The first five years of life are biologically fragile. A young child's immune system is still developing and doesn't yet know how to fight many infections. That's where vaccines step in—offering essential protection before natural defences mature. Diseases like measles, diphtheria, and polio don't give you time to prepare. They strike quickly, and in unvaccinated children, can cause complications that leave lasting damage, or worse. Global immunisation programs, such as the Expanded Programme on Immunisation (EPI), have prevented over 150 million child deaths since 1974. The numbers speak for themselves.
2. Building a safety net for all
Vaccines work best when most people get them. When a large part of the population—about 95%—is immunised, it creates a buffer that protects even those who aren't vaccinated, such as newborns or children undergoing medical treatments. When enough children in a community are vaccinated, it creates a protective barrier that slows the spread of disease,even to those who aren't immunised. Herd immunity is effective only when a sufficient number of children are vaccinated. But measles shots have been slipping through the cracks. In 2024, only 84% of children worldwide received protection, far short of the mark needed to prevent outbreaks. As a result, measles made a comeback in over 60 countries, even in places where it hadn't shown up in years.
3. Reducing health inequity
Children who miss vaccines aren't always in far-off regions. Even in India, access to routine immunisation depends heavily on geography and infrastructure. Children in urban slums, tribal belts, or conflict-affected areas often fall through the cracks. That's why national efforts like Mission Indradhanush were launched—to reach the last-mile child in India. When parents everywhere ensure their children are vaccinated, it not only protects their homes but also helps reduce the health gap between rural and urban India.
4. Avoiding preventable costs
Beyond health, the cost of vaccine-preventable diseases can be high—hospital bills, lost workdays, and slow recoveries take their toll. In the US, regular childhood vaccines are estimated to have saved over $2.7 trillion in societal costs. The figures may differ in India, but the message is clear: stopping disease before it starts is always the wiser investment.
5. Fighting misinformation with awareness
The internet is full of misleading claims—some sounding all too credible. Worries about vaccine safety, doubts over their need, or fear of side effects can cause parents to delay or miss doses. However, even brief delays can allow disease to take hold. Vaccines undergo years of rigorous testing and are supported by real-world evidence. Today, the greater risk isn't from the vaccine—it's from the disease waiting on the other side of hesitation.
What can parents do?
Stick to the national immunisation schedule. Delays reduce effectiveness and increase risk.
Maintain a vaccination card or record. This helps track doses and is often required during emergencies or travel.
Speak to your paediatrician. Whether you have doubts or missed a shot, an honest conversation helps.
Check requirements if relocating. Different regions may carry different disease risks—stay informed.
Vaccination is one of the simplest, most powerful ways to secure your child's health. It's not just about disease prevention—it's about giving children the freedom to grow, play, and learn without fear.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WHO updates recommendations on use of antibiotics for Covid-19 patients
WHO updates recommendations on use of antibiotics for Covid-19 patients

Business Standard

timean hour ago

  • Business Standard

WHO updates recommendations on use of antibiotics for Covid-19 patients

The WHO has recommended against the use of antibiotics even in patients with severe Covid when a concurrent bacterial infection is not suspected. The global health body has released updated recommendations for the clinical management of people with Covid which, it said, are based on evidence generated from recent meta-analysis of outcomes of patients treated with antibiotics for Covid. "For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics. For patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we suggest no empirical antibiotics," the WHO said. The WHO said that as COVID-19 epidemiology and severity have changed, and as emergency measures have subsided, the evidence behind a number of recommendations has changed. In parallel, evolution of health systems and the global environment have meant that the recommendations are implemented in a very different context in 2024 compared to 2020. These guidelines have evolved from the first version in 2020 in line with new information and changing circumstances of the pandemic, the WHO said. "Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity. Emergency measures which were imposed have also been removed, and care for patients with COVID-19 has become more integrated with usual healthcare systems. "This different environment has prompted a review of the scope and content of all existing guidance. In order to maintain a clear focus and relevance, we have removed recommendations which would be considered general medical principles, and those which are no longer specific to the management of COVID-19," the WHO said. The new recommendations on use of antibiotics were prompted by the publication of data from a systematic review and meta-analysis, and the pressing need to address antimicrobial resistance. The WHO said that the updated guidelines are for people directly or indirectly involved in the health care of patients with COVID-19 and post COVID-19 condition. This includes clinicians, allied health care workers, facility managers and hospital administrators. The SARS-CoV-2 continues to infect several thousands of people daily leading to preventable morbidity and mortality across the world, the WHO said. The roll-out of vaccines and treatment for COVID-19, and increasing population immunity from infection has substantially reduced hospitalization, severity of disease, and mortality. "However, the virus continues to evolve in terms of infectivity, immune escape, and disease severity. This guideline robustly and transparently addresses the changing landscape and evidence availability, and the continual development of treatment and management strategies for COVID-19," the WHO stated. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

WHO updates recommendations on use of antibiotics for COVID-19 patients
WHO updates recommendations on use of antibiotics for COVID-19 patients

News18

time2 hours ago

  • News18

WHO updates recommendations on use of antibiotics for COVID-19 patients

New Delhi, Aug 6 (PTI) The WHO has recommended against the use of antibiotics even in patients with severe Covid when a concurrent bacterial infection is not suspected. The global health body has released updated recommendations for the clinical management of people with Covid which, it said, are based on evidence generated from recent meta-analysis of outcomes of patients treated with antibiotics for Covid. 'For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics. For patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we suggest no empirical antibiotics," the WHO said. The WHO said that as COVID-19 epidemiology and severity have changed, and as emergency measures have subsided, the evidence behind a number of recommendations has changed. In parallel, evolution of health systems and the global environment have meant that the recommendations are implemented in a very different context in 2024 compared to 2020. These guidelines have evolved from the first version in 2020 in line with new information and changing circumstances of the pandemic, the WHO said. 'Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity. Emergency measures which were imposed have also been removed, and care for patients with COVID-19 has become more integrated with usual healthcare systems. 'This different environment has prompted a review of the scope and content of all existing guidance. In order to maintain a clear focus and relevance, we have removed recommendations which would be considered general medical principles, and those which are no longer specific to the management of COVID-19," the WHO said. The new recommendations on use of antibiotics were prompted by the publication of data from a systematic review and meta-analysis, and the pressing need to address antimicrobial resistance. The WHO said that the updated guidelines are for people directly or indirectly involved in the health care of patients with COVID-19 and post COVID-19 condition. This includes clinicians, allied health care workers, facility managers and hospital administrators. The SARS-CoV-2 continues to infect several thousands of people daily leading to preventable morbidity and mortality across the world, the WHO said. The roll-out of vaccines and treatment for COVID-19, and increasing population immunity from infection has substantially reduced hospitalization, severity of disease, and mortality. 'However, the virus continues to evolve in terms of infectivity, immune escape, and disease severity. This guideline robustly and transparently addresses the changing landscape and evidence availability, and the continual development of treatment and management strategies for COVID-19," the WHO stated. PTI PLB ZMN view comments First Published: August 06, 2025, 22:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Need For A Comprehensive International Health Law Post-Covid: In Light Of New WHO Pandemic Treaty
Need For A Comprehensive International Health Law Post-Covid: In Light Of New WHO Pandemic Treaty

News18

time3 hours ago

  • News18

Need For A Comprehensive International Health Law Post-Covid: In Light Of New WHO Pandemic Treaty

While health has historically been viewed as a domestic responsibility, Covid-19 reinforced the fact that infectious diseases transcend borders The Covid-19 pandemic manifested the urgent need to strengthen international health law. Historically, health governance has largely been considered a national matter, regulated primarily through municipal laws. Although the World Health Organization (WHO) is one of the oldest international institutions within international law, the over-reliance on national legal frameworks has hindered the development of a comprehensive international treaty on health law. At present, international health governance relies primarily on soft international law, i.e., non-binding instruments such as guidelines, recommendations, and best practices for member states. However, the Covid-19 pandemic exposed gaps in global preparedness and response mechanisms, necessitating the need for a binding international treaty to coordinate pandemic prevention, preparedness, and equitable response across nations. The International Health Regulations (IHR) 2005, though adopted by 196 countries, proved insufficient to manage a crisis of this scale. The IHR 2005 replaced the older IHR 1969, which had focused mainly on controlling specific diseases such as cholera, plague, and yellow fever. It was adopted under Article 21 of the WHO Constitution; however, the 2005 regulations expanded their scope but still relied on state compliance without strong enforcement mechanisms. The pandemic also reinvigorated the debate surrounding whether public health should be treated as part of the global commons. Historically, international law identifies areas such as the high seas, outer space, Antarctica, and the deep seabed as global commons, which are resources beyond national jurisdiction and accessible for the collective benefit of humankind. While health has historically been viewed as a domestic responsibility, Covid-19 reinforced the fact that infectious diseases transcend borders, affecting the entire international community. This would impose collective obligations on states to share resources, technology, and data, particularly in pandemic situations. It would also require a shift from national interest-based approaches to collective international cooperation, ensuring equitable access to vaccines, medicines, and diagnostics. The proposed WHO Pandemic Agreement partially reflects this approach by emphasising pandemic prevention, preparedness, and equitable response. India's Vaccine Maitri: A Case of Health Diplomacy India's Vaccine Maitri (Vaccine Friendship) initiative put into practice the global commons approach in practice. Launched in January 2021, the program aimed at supplying Covid-19 vaccines to low- and middle-income countries, reflecting India's commitment to 'Vasudhaiva Kutumbakam" (the world is one family). India exported millions of doses of vaccines to over 90 countries, including those in Africa, Asia, Latin America, and the Caribbean. This initiative was not only a form of health diplomacy but also an effort to implement the principle of equity in global health governance. By prioritising vaccine access for developing countries, India contributed to global solidarity and demonstrated how states can play a rule-shaping role in international health law, even in the absence of a binding treaty. Vaccine Maitri can serve as an example for future obligations under the proposed Pandemic Agreement, especially regarding technology transfer, intellectual property waivers, and equitable distribution of medical resources. Towards a WHO Pandemic Agreement Recognising the devastating loss of life, economic disruptions, and setbacks to global development caused by Covid-19, WHO Member States emphasised the need for permanent global action to prevent similar crises in the future. The objective of the new treaty, often referred to as the WHO Pandemic Agreement, is to ensure that communities, governments, and all sectors of society are better prepared, protected, and able to respond equitably to future pandemics. To negotiate this treaty, WHO Member States established the Intergovernmental Negotiating Body (INB), which held its first meeting on February 24, 2022. The INB process has since involved 13 formal rounds of meetings, alongside multiple formal and informal consultations to discuss complex provisions of the treaty for securing the future. The INB submitted its first outcome at the Seventy-seventh World Health Assembly in May 2024. The final draft has been submitted for consideration at the Seventy-eighth World Health Assembly in May 2025. The draft addresses gaps and inequities exposed by the Covid-19 pandemic, focusing on equitable access to health products, coordinated funding, and strengthened prevention and response mechanisms. Abhinav Mehrotra and Dr Biswanath Gupta are Associate Professors at OP Jindal Global University. Views expressed in the above piece are personal and solely those of the authors. They do not necessarily reflect News18's views. First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store